CoChat

A Reliable Tool to Determine Cell Viability in Complex 3-D Culture: The Acid Phosphatase Assay

Open access
Friedrich, Juergen, Eder, Wolfgang, Castaneda, Juana, Doss, Markus, Huber, Elisabeth, Ebner, Reinhard, Kunz-Schughart, Leoni A. · 2007 · SLAS DISCOVERY

The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.

Abstract

Cell-based assays are more complex than cell-free test systems but still reflect a highly artificial cellular environment. Incorporation of organotypic 3-dimensional (3-D) culture systems into mainstream drug development processes is increasingly discussed but severely limited by complex methodological requirements. The objective of this study was to explore a panel of standard assays to provide an easy-handling, standardized protocol for rapid routine analysis of cell survival in multicellular tumor spheroid-based antitumor drug testing. Spheroids of 2 colon carcinoma cell lines were characterized for evaluation. One of the assay systems tested could reliably be used to determine cell viability in spheroids. The authors verified that the acid phosphatase assay (APH) is applicable for single spheroids in 96-well plates, does not require spheroid dissociation, and is linear and highly sensitive for HT29 and HCT-116 spheroids up to diameters of 650 microm and 900 microm, consisting of 40,000 and 80,000 cells, respectively. Treatment of HT29 and HCT-116 cells with 5-fluorouracil, Irinotecan, and C-1311 revealed critically reduced drug efficacies in 3-D versus monolayer culture, which is discussed in light of literature data. The experimental protocol presented herein is a small but substantial contribution to the establishment of sophisticated 3-D in vitro systems in the antitumor drug screening scenario.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1087057107306839

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Research works printed but not linked: 1

  1. Chau M, Otake Y, Christensen JL, Fernandes DJ, Ajami AM: The imidazoacridinone, C-1311(SymadexTM): the first of a potent new class of FLT3 inhibitors [abstract B35]. Paper presented at the 2006 American Association for Cancer Research (AACR) International Conference on Molecular Diagnostics in Cancer Therapeutic Development, Chicago, September 14, 2006.

Cited by

See all 228

Metadata

Authors
Friedrich, J., Eder, W., Castaneda, J., Doss, M., Huber, E., Ebner, R., & Kunz-Schughart, L. A.
Affiliations
  • University of Regensburg (DE)
  • Avalon Pharma (United States) (US)
Venue
SLAS DISCOVERY
Publisher
Elsevier BV
Published
2007-10
Volume
12
Issue
7
Pages
925-937
ISSN
2472-5552 (ISSN-L)
OpenAlex
W2138969252
Cited by
227
References
56
Citations by year
2026: 11 · 2025: 11 · 2024: 12 · 2023: 7 · 2022: 14 · 2021: 13 · 2020: 19 · 2019: 16 · 2018: 16 · 2017: 21 · 2016: 17 · 2015: 10 · 2014: 14 · 2013: 15 · 2012: 7
FWCI
3.82
Type
journal article
Language
en
Update notices
erratum (2007-12-01)
Open access
Licence
Locations
  • SLAS DISCOVERY (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
Funders
Bundesministerium für Bildung und Forschung
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Keywords
cell viability, tumor spheroids, 3D cell culture, anticancer drug screening, colon cancer, HT-29 cells, HCT116 cells, 5-fluorouracil, irinotecan, drug efficacy, spheroid size
MeSH terms
Acid Phosphatase, Cell Survival, Colonic Neoplasms, Flow Cytometry, Humans, Reproducibility of Results, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Reliable Tool to Determine Cell Viability in Complex 3-D Culture: The Acid Phosphatase Assay. https://app.cochat.ai/papers/10.1177/1087057107306839
The paper
Friedrich, J., Eder, W., Castaneda, J., Doss, M., Huber, E., Ebner, R., & Kunz-Schughart, L. A. (2007). A Reliable Tool to Determine Cell Viability in Complex 3-D Culture: The Acid Phosphatase Assay. SLAS DISCOVERY. https://doi.org/10.1177/1087057107306839

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.